DK0662146T3 - Dorsalvævpåvirkende faktor og præparat - Google Patents
Dorsalvævpåvirkende faktor og præparatInfo
- Publication number
- DK0662146T3 DK0662146T3 DK93922151T DK93922151T DK0662146T3 DK 0662146 T3 DK0662146 T3 DK 0662146T3 DK 93922151 T DK93922151 T DK 93922151T DK 93922151 T DK93922151 T DK 93922151T DK 0662146 T3 DK0662146 T3 DK 0662146T3
- Authority
- DK
- Denmark
- Prior art keywords
- noggin
- seq
- preparation
- dorsal
- influencing factor
- Prior art date
Links
- 102000045246 noggin Human genes 0.000 abstract 7
- 108700007229 noggin Proteins 0.000 abstract 7
- 102000005606 Activins Human genes 0.000 abstract 1
- 108010059616 Activins Proteins 0.000 abstract 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 239000000488 activin Substances 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 210000003716 mesoderm Anatomy 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93995492A | 1992-09-03 | 1992-09-03 | |
| PCT/US1993/008325 WO1994005800A1 (en) | 1992-09-03 | 1993-09-02 | Dorsal tissue affecting factor and compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0662146T3 true DK0662146T3 (da) | 2000-11-13 |
Family
ID=25473995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93922151T DK0662146T3 (da) | 1992-09-03 | 1993-09-02 | Dorsalvævpåvirkende faktor og præparat |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5670481A (pt) |
| EP (1) | EP0662146B1 (pt) |
| AT (1) | ATE194658T1 (pt) |
| AU (1) | AU5125693A (pt) |
| DE (1) | DE69329031T2 (pt) |
| DK (1) | DK0662146T3 (pt) |
| ES (1) | ES2149823T3 (pt) |
| GR (1) | GR3034554T3 (pt) |
| PT (1) | PT662146E (pt) |
| WO (1) | WO1994005800A1 (pt) |
| ZA (1) | ZA936478B (pt) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5679783A (en) * | 1994-11-22 | 1997-10-21 | The Regents Of The University Of California | DNA encoding a tissue differentiation affecting factor |
| US6133232A (en) * | 1996-06-20 | 2000-10-17 | The Regents Of The University Of California | Endoderm, cardiac and neural inducing factors |
| WO1998033918A1 (en) * | 1997-02-05 | 1998-08-06 | The Regents Of The University Of California | Morphogenic proteins |
| WO1998037195A1 (en) * | 1997-02-19 | 1998-08-27 | Regeneron Pharmaceuticals, Inc. | Morphogenic proteins |
| US6075007A (en) * | 1997-07-17 | 2000-06-13 | Regeneron Pharmaceuticals, Inc. | Modified noggin polypeptide and compositions |
| WO1999061044A1 (en) * | 1998-05-28 | 1999-12-02 | The Board Of Trustees Of The University Of Arkansas | Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption |
| US6087168A (en) | 1999-01-20 | 2000-07-11 | Cedars Sinai Medical Center | Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells |
| TWI267378B (en) | 2001-06-08 | 2006-12-01 | Wyeth Corp | Calcium phosphate delivery vehicles for osteoinductive proteins |
| KR101161784B1 (ko) | 2003-04-11 | 2012-07-05 | 에텍스 코포레이션 | 골 유도성 골 물질 |
| ES2282904T3 (es) | 2003-09-12 | 2007-10-16 | Wyeth | Barras solidas de fosfato calcico inyectables para el suministro de proteinas osteogenicas. |
| US7473678B2 (en) | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
| WO2007028212A1 (en) * | 2005-09-08 | 2007-03-15 | Apollo Life Sciences Limited | Noggin and chimeric molecules thereof |
| US8147860B2 (en) | 2005-12-06 | 2012-04-03 | Etex Corporation | Porous calcium phosphate bone material |
| CA2641860C (en) | 2006-02-09 | 2015-07-14 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating bone |
| ES2664229T3 (es) | 2006-06-30 | 2018-04-18 | Biomimetic Therapeutics, Llc | Composiciones y métodos de biomatriz-PDGF para el tratamiento de lesiones del manguito rotador |
| US9161967B2 (en) | 2006-06-30 | 2015-10-20 | Biomimetic Therapeutics, Llc | Compositions and methods for treating the vertebral column |
| US20090061002A1 (en) | 2007-09-05 | 2009-03-05 | Venbrocks Rudolf A | Calcium phospate based delivery of growth and differentiation factors to compromised bone |
| AU2009291828C1 (en) | 2008-09-09 | 2016-03-17 | Biomimetic Therapeutics, Llc | Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries |
| US8492335B2 (en) | 2010-02-22 | 2013-07-23 | Biomimetic Therapeutics, Llc | Platelet-derived growth factor compositions and methods for the treatment of tendinopathies |
| WO2014012101A1 (en) | 2012-07-13 | 2014-01-16 | Trustees Of Tufts College | Silk powder compaction for production of constructs with high mechanical strength and stiffness |
| ES2846848T3 (es) | 2015-10-26 | 2021-07-29 | Harvard College | Polisacáridos reducidos y oxidados y métodos de uso de los mismos |
| US10961305B2 (en) | 2016-12-21 | 2021-03-30 | Mereo Biopharma 3 Limited | Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta |
| AT521641B1 (de) * | 2018-09-12 | 2020-07-15 | Fianostics Gmbh | Verfahren zur Diagnose von Lebererkrankungen |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0491675A1 (en) * | 1984-01-30 | 1992-06-24 | Imperial Cancer Research Technology Limited | Improvements relating to growth factors |
| JPS62502589A (ja) * | 1985-04-11 | 1987-10-08 | ザ・チヤイルドレンズ・メデイカル・センタ−・コ−ポレ−シヨン | フオン・ビルブラント因子 |
| US5030576A (en) * | 1986-04-30 | 1991-07-09 | Genentech, Inc. | Receptors for efficient determination of ligands and their antagonists or agonists |
| US4857637A (en) * | 1986-05-07 | 1989-08-15 | Genentech, Inc. | Methods and compositions for immunologically modulating growth hormone receptor activity |
| IN165717B (pt) * | 1986-08-07 | 1989-12-23 | Battelle Memorial Institute | |
| US5149637A (en) * | 1987-04-06 | 1992-09-22 | Scripps Clinic & Research Foundation | Recombinant Factor VIIIC fragments |
| GB8822147D0 (en) * | 1988-09-21 | 1988-10-26 | Ciba Geigy Ag | Pharmaceutically active combination |
| US5098833A (en) * | 1989-02-23 | 1992-03-24 | Genentech, Inc. | DNA sequence encoding a functional domain of a lymphocyte homing receptor |
| US5194596A (en) * | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
| US5229500A (en) * | 1989-08-30 | 1993-07-20 | Regeneron Pharmaceuticals, Inc. | Brain derived neurotrophic factor |
| IL95511A (en) * | 1989-08-30 | 2000-10-31 | Max Planck Gesellschaft | Neurotrophin-3 a novel neurotrophic factor related to nerve growth and brain derived neurotrophic factor |
| ATE140966T1 (de) * | 1990-09-25 | 1996-08-15 | Genentech Inc | Neuer neurotropischer faktor |
-
1993
- 1993-09-02 DK DK93922151T patent/DK0662146T3/da active
- 1993-09-02 WO PCT/US1993/008325 patent/WO1994005800A1/en active IP Right Grant
- 1993-09-02 ES ES93922151T patent/ES2149823T3/es not_active Expired - Lifetime
- 1993-09-02 AT AT93922151T patent/ATE194658T1/de active
- 1993-09-02 PT PT93922151T patent/PT662146E/pt unknown
- 1993-09-02 DE DE69329031T patent/DE69329031T2/de not_active Expired - Lifetime
- 1993-09-02 EP EP93922151A patent/EP0662146B1/en not_active Expired - Lifetime
- 1993-09-02 ZA ZA936478A patent/ZA936478B/xx unknown
- 1993-09-02 AU AU51256/93A patent/AU5125693A/en not_active Abandoned
-
1994
- 1994-08-29 US US08/297,633 patent/US5670481A/en not_active Expired - Lifetime
-
2000
- 2000-10-04 GR GR20000402244T patent/GR3034554T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0662146B1 (en) | 2000-07-12 |
| EP0662146A4 (en) | 1996-03-13 |
| DE69329031D1 (de) | 2000-08-17 |
| US5670481A (en) | 1997-09-23 |
| EP0662146A1 (en) | 1995-07-12 |
| ATE194658T1 (de) | 2000-07-15 |
| PT662146E (pt) | 2000-12-29 |
| GR3034554T3 (en) | 2001-01-31 |
| ZA936478B (en) | 1994-09-30 |
| WO1994005800A1 (en) | 1994-03-17 |
| AU5125693A (en) | 1994-03-29 |
| ES2149823T3 (es) | 2000-11-16 |
| DE69329031T2 (de) | 2001-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0662146T3 (da) | Dorsalvævpåvirkende faktor og præparat | |
| IL97758A0 (en) | Epithelins:cysteine-rich growth modulating proteins | |
| MX9602259A (es) | Proteina modificada quimicamente en el nitrogeno terminal, composiciones que las incluyen y metodos para su preparacion. | |
| DE59007517D1 (de) | Neue proteine mit tnf-hemmender wirkung und ihre herstellung. | |
| JPH0395199A (ja) | グリオーマ由来増殖因子の精製及び特徴 | |
| BG105764A (en) | Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant | |
| DK0728146T3 (da) | Conotoxinpeptider | |
| YU71395A (sh) | Acilovani analozi insulina | |
| MY123371A (en) | Protein for blocking platelet adhesion | |
| DE69942035D1 (de) | Menschliches parathyroidhormon, modifikationen, herstellung und verwendung | |
| CA2104678A1 (en) | Protein-induced morphogenesis | |
| HK1032426A1 (en) | Amino-terminally truncated rantes as chemokine antagonists | |
| EP0307513A3 (en) | Pulmonary hydrophobic surfactant-associated proteins | |
| SUNADA et al. | Mechanism of collagen degradation by collagenase: a transition process of the collagen molecule from collagenase-substrate to gelatinase-substrate | |
| EP0241136A3 (en) | Human class 1 heparin-binding growth factor | |
| AU8302791A (en) | Recombinant gene coding for a protein having an endochitinase activity | |
| ATE325812T1 (de) | Menschliches, gebärmutterkrebs-spezifisches suppressorprotein, für das protein kodieres polynukleotid, mit dem polynukleotid transformierte zelle und verfahren zur unterdrückung der proliferation von krebszellen unter verwendung des expressionsvektors | |
| CA2033730A1 (en) | Heparin-binding growth factor | |
| WO2001080811A3 (en) | Mmp-2 propeptide for use as antiangiogenic or antitumor agent | |
| Shoyah et al. | Epitheli | |
| EP1295943A4 (en) | POLYPEPTIDES CAPABLE THE POWER TO STIMULATE NEUTROPHILES | |
| EP0556395A4 (en) | Novel cytokine | |
| NO923861L (no) | Epiteliner: nye vekstregulerende proteiner |